President Trump has actually called a speculative coronavirus treatment he received “a present from Paradise” and promised to make it widely available– sparking yet another round of concern about politics intruding on science.
What they’re stating: “We have an emergency usage authorization that I want to get signed instantly,” Trump stated in a video Thursday.
The big image: “The problem is every therapy for coronavirus has actually become politicized– every therapy, which’s the last thing you desire in a pandemic, so this is simply next in line,” Walid Gellad, director of the Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh, told the Washington Post
Trump is talking about a cocktail of laboratory-made antibodies made by Regeneron that he got as part of a host of medications over the past week.
- Regeneron and Eli Lilly, which is developing a comparable therapy, both requested an emergency situation usage authorization from the FDA this week.
- Regeneron has stated that it would have about 300,000 doses of the drug readily available in the next couple of months, and Eli Lilly will have about 1 million doses prepared by the end of the year, per the Post.
- That indicates that even if the drugs are rapidly authorized, the variety of clients who can get them will be restricted.
In between the lines: The drugs, while promising, are still undergoing scientific trials, and it’s uncertain whether the Regeneron treatment was accountable for Trump’s evident healing.
What to enjoy: “The science of antibody drugs could … degenerate into another political conflict.”
- ” But the FDA must and will weigh the advantages of the treatment against the dangers and judge the application on the scientific merits, ideally without political disturbance,” former FDA commissioners Scott Gottlieb and Mark McClellan wrote in a Wall Street Journal op-ed the other day.
Comments
Post a Comment